OMDA OMADA HEALTH INC

Omada Health to Participate in Evercore Healthcare Conference

Omada Health to Participate in Evercore Healthcare Conference

SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8th Annual Evercore Healthcare Conference, taking place in Miami, including a fireside chat on Wednesday, December 3, 2025, at 1:20 pm ET. The webcast will be available online at . A replay will also be available at the same link following the event.

About Omada Health

(Nasdaq: OMDA) is a virtual between-visit healthcare provider that addresses cardiometabolic conditions including diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. Through specialized care tracks, Omada also supports members taking GLP-1s and other anti-obesity medications. Our unique approach of Compassionate Intelligence combines human-led care teams, connected devices, and AI-powered technology to deliver personalized care at scale.

With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada has served over one million members since launch across more than 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s. Its evidence-based approach and commitment to bending the curve of chronic disease has earned the company multiple healthcare accreditations and recognition in the industry.

As a trusted partner in the healthcare ecosystem, Omada delivers measurable results that help improve health outcomes while containing healthcare costs. For more information, visit omadahealth.com.

Contacts

Allan Kells

Rose Ramseth



EN
20/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OMADA HEALTH INC

 PRESS RELEASE

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the...

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk Omada for Cholesterol closes a critical gap in cardiovascular care, delivering between-visit support for the many adults whose LDL remains uncontrolled under usual care¹ SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, today announced the expansion of its integrated platform to include dedicated cholesterol management alongside weight, glucose, blood pressure, and GLP-1 support. Up to 70% of adults with obesity...

 PRESS RELEASE

Omada Health to Announce Fourth Quarter and Full Year 2025 Financial R...

Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026 SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its fourth quarter and full year 2025 results on Thursday, March 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at . A replay will be available shortly after the conclusion of the cal...

 PRESS RELEASE

Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Qua...

Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025 SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Preliminary, unaudited revenue for the fourth quarter of 2025 is expected to be between $72 million and $74 million, representing an increase of 50% to 54% over t...

 PRESS RELEASE

Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Las...

Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidence SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced from a 12-month real-world analysis of members in its GLP-1 companion program. By extending a previous six-month , findings underscore the program’s role in helping employers manage the...

 PRESS RELEASE

Omada Health to Participate in J.P. Morgan Healthcare Conference

Omada Health to Participate in J.P. Morgan Healthcare Conference SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, including a presentation on Wednesday, Jan. 14, at 9 a.m. PST. The webcast will be available online at . A replay will also be available at the same link following the event. About Omada Health (Nasdaq: OMDA) is a virtual between-visit healthcare provider that a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch